One of the listed companies, Silva Pharmaceuticals Limited discloses its financial reports for the first quarter, (July-September 23).
The company’s earnings per share (EPS) loss of Tk 0.06 paisa in Q1 of the current financial year (July-September 23). EPS Tk 0.19 paisa during the same period last year. NAV per share was of Tk. 17.04 as of September 30, 2023.
Share this
